Published in Br J Cancer on November 30, 2010
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol (2012) 1.66
Recent advances in the molecular understanding of glioblastoma. J Neurooncol (2012) 1.29
Targeting Aggressive Cancer Stem Cells in Glioblastoma. Front Oncol (2015) 1.05
Altered expression of polycomb group genes in glioblastoma multiforme. PLoS One (2013) 0.95
Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma. J Cell Mol Med (2012) 0.90
Evolutionary etiology of high-grade astrocytomas. Proc Natl Acad Sci U S A (2013) 0.89
Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients. BMC Bioinformatics (2013) 0.89
TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1.). Oncogene (2013) 0.88
Integrative physical oncology. Wiley Interdiscip Rev Syst Biol Med (2011) 0.88
Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification. Clin Neuroradiol (2014) 0.87
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells. Neuro Oncol (2013) 0.86
Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Semin Radiat Oncol (2015) 0.85
Frontiers in Suicide Gene Therapy of Cancer. J Genet Syndr Gene Ther (2012) 0.83
CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget (2015) 0.82
Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them? Front Neurol (2013) 0.82
A mathematical model for short-term vs. long-term survival in patients with glioma. Am J Cancer Res (2014) 0.82
Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation. Mutagenesis (2014) 0.81
An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma. Mol Med Rep (2015) 0.81
Contemporary murine models in preclinical astrocytoma drug development. Neuro Oncol (2014) 0.81
Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas. PLoS One (2013) 0.81
Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. Neuro Oncol (2016) 0.80
Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes. PLoS One (2012) 0.79
Investigation of adhesion and mechanical properties of human glioma cells by single cell force spectroscopy and atomic force microscopy. PLoS One (2014) 0.79
Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice. J Vis Exp (2014) 0.79
Glioblastoma: Overview of Disease and Treatment. Clin J Oncol Nurs (2016) 0.77
Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival. Br J Cancer (2013) 0.76
Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer. Mol Med Rep (2015) 0.76
Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients. Sci Rep (2016) 0.75
Pushing the limits of glioma resection using electrophysiologic brain mapping. J Clin Oncol (2012) 0.75
Microarray analysis in a cell death resistant glioma cell line to identify signaling pathways and novel genes controlling resistance and malignancy. Cancers (Basel) (2011) 0.75
Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer. PLoS One (2016) 0.75
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci (2009) 8.38
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell (2006) 8.09
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res (2003) 8.06
Gene expression profiling of gliomas strongly predicts survival. Cancer Res (2004) 7.79
Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst (2007) 7.44
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol (2008) 6.41
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One (2009) 5.08
Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene (2003) 3.83
Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res (2009) 3.58
A multigene predictor of outcome in glioblastoma. Neuro Oncol (2009) 3.57
Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res (2006) 3.41
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res (2009) 3.22
Gene expression profiling identifies molecular subtypes of gliomas. Oncogene (2003) 3.13
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res (2005) 3.10
Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90
Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res (2005) 2.63
Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res (2009) 2.42
Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J Clin Oncol (2006) 2.41
Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol (2003) 2.38
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genomics (2008) 2.29
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol (2010) 2.23
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res (2003) 2.15
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol (2007) 1.88
Glioblastoma. Arch Pathol Lab Med (2007) 1.71
What should physicians look for in evaluating prognostic gene-expression signatures? Nat Rev Clin Oncol (2010) 1.29
Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis. Clin Cancer Res (2007) 1.26
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol (1998) 3.32
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol (1998) 1.88
HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem (2001) 1.71
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene (2006) 1.70
Pediatric imaging perspective: the vomiting infant. J Pediatr (1998) 1.40
A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol (1999) 1.39
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Oncogene (2009) 1.16
Role of LKB1 in lung cancer development. Br J Cancer (2008) 1.14
Validity of rating of perceived exertion during graded exercise testing in apparently healthy adults and cardiac patients. J Cardiopulm Rehabil (1997) 1.14
PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer. Oncol Rep (2007) 1.11
CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis (1993) 1.05
Virginiamycin for prevention of swine dysentery. Vet Med Small Anim Clin (1972) 1.02
The relationship of congenital heart disease and respiratory infection mortality in patients with Down's syndrome. J Ment Defic Res (1985) 1.00
Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. J Am Acad Dermatol (1994) 0.98
Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the rat. Toxicol Appl Pharmacol (1989) 0.98
Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect (1992) 0.93
Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1999) 0.93
Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5. Dis Esophagus (2011) 0.91
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer. Br J Cancer (2012) 0.90
Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation. Oncogene (2012) 0.89
Effect of morphine on 3H-thymidine incorporation in the subependyma of the rat: an autoradiographic study. J Comp Neurol (1982) 0.89
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer (2013) 0.89
Arthrodesis of the scapulohumeral joint in a miniature horse. J Am Vet Med Assoc (1987) 0.87
Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro. Clin Cancer Res (2000) 0.86
Resolution of Budd-Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1996) 0.85
The effects of methyl-5(6)-butyl-2-benzimidazole carbamate (parbendazole) on reproduction in sheep and other animals. II. Teratological study in ewes in the United States. Cornell Vet (1974) 0.84
Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats. Eur J Pharmacol (2000) 0.84
Effects of dietary virginiamycin on performance and liver abscess incidence in feedlot cattle. J Anim Sci (1995) 0.83
Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes. Gene Ther (1996) 0.83
Natural history of mental retardation in a state hospital, revisited. Releases and deaths in two admission groups, ten years apart. Am J Dis Child (1969) 0.83
Spectrum of chest radiographic abnormalities in children with AIDS and Pneumocystis carinii pneumonia. Pediatr Radiol (1995) 0.83
Purification and characterization of a peptidyl glycine monooxygenase from porcine pituitary. Endocrinology (1986) 0.82
Effect of different levels and periods of lead exposure on tissue levels and excretion of lead, zinc, and calcium in the rat. Fundam Appl Toxicol (1987) 0.82
A rapid, sensitive assay for glycine-directed amidating enzymes. J Neurosci Methods (1985) 0.81
Comparison of respiratory mortality in the profoundly mentally retarded and in the less retarded. J Ment Defic Res (1979) 0.81
Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol Biomarkers Prev (1999) 0.80
Renal cell carcinoma after therapy for neuroblastoma. AJR Am J Roentgenol (1996) 0.80
Multifocal Langerhans cell histiocytosis of the pediatric spine: a case report and literature review. Childs Nerv Syst (2006) 0.80
Anaplastic renal cell carcinoma following neuroblastoma. Med Pediatr Oncol (1995) 0.79
Intrauterine infection on an obstetric service. Obstet Gynecol (1974) 0.79
The Effects of Ice Massage on an Individual's Pain Tolerance Level to Electrical Stimulation. J Orthop Sports Phys Ther (1990) 0.79
General activity in hamsters with septal lesions. Physiol Behav (1972) 0.77
EGFR regulation by microRNA in lung cancer: a rose by any other name ... is an increasingly complicated rose. Ann Oncol (2008) 0.77
Reproductive toxicity screen of 1,3,5-trinitrobenzene administered in the diet of Sprague-Dawley rats. Toxicol Ind Health (1995) 0.77
Tissue residue studies in swine treated with virginiamycin. J Agric Food Chem (1973) 0.76
Pathogenomic mechanisms for particulate matter induction of acute lung injury and inflammation in mice. Res Rep Health Eff Inst (2001) 0.76
Lead accumulation by rat renal brush border membrane vesicles. J Pharmacol Exp Ther (1984) 0.76
Influence of a sub-therapeutic level of virginiamycin in feed on the incidence and persistence of Salmonella typhimurium in experimentally infected swine. J Anim Sci (1979) 0.76
Granulomatous bronchiolitis of Crohn's disease successfully treated with inhaled budesonide. Thorax (2009) 0.76
Mortality and cause of death in a hospital for the mentally retarded. Am J Public Health Nations Health (1968) 0.75
Costs at for-profit and at not-for-profit hospitals. N Engl J Med (1997) 0.75
Postgraduate pharmacy fellowships (1983-1984). Drug Intell Clin Pharm (1983) 0.75
Antenatal ultrasonographic diagnosis of rhizomelic chondrodysplasia punctata. J Ultrasound Med (1999) 0.75
Toxicologic and teratologic studies of oxibendazole in ruminants and laboratory animals. Am J Vet Res (1977) 0.75
Partitioning of renal zinc between metallothionein and ethylenediaminetetraacetic acid (EDTA) after treatment of rats with Ca(Na)2EDTA. Toxicol Appl Pharmacol (1986) 0.75
The significance of facial burns in acute smoke inhalation. Crit Care Med (1980) 0.75
General toxicity and reproductive screen of liquid propellant XM46 administered in the drinking water of Sprague-Dawley rats. Toxicol Ind Health (1996) 0.75
Correction to postgraduate pharmacy fellowships. Drug Intell Clin Pharm (1984) 0.75
Selected variables of institutional employees by patient contact and length of employment. Am J Ment Defic (1967) 0.75
Spikes, Local Field Potentials, and Electrocorticogram Characterization during Motor Learning in Rats for Brain Machine Interface Tasks. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Early brain recurrences are potentially detectable in asymptomatic, early stage lung adenocarcinoma. Clin Oncol (R Coll Radiol) (2011) 0.75
The effects of methyl-5(6)-butyl-2-benzimidazole carbamate (parbendazole) on reproduction in sheep and other animals. VI. Effect in the pregnant cow. Cornell Vet (1974) 0.75
A biologically based pharmacodynamic model for lipid peroxidation stimulated by trichloroethylene in vitro. J Biochem Mol Toxicol (1999) 0.75
Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation. Oncogene (2015) 0.75
Disruption of a radiation-induced preference shift by hippocampal lesions. Physiol Behav (1971) 0.75
Life expectancy and mental retardation. A longitudinal study in a state residential facility. Monogr Am Assoc Ment Defic (1987) 0.75
Experience with a chamber for continuous negative pressure treatment of infants with respiratory distress. Respir Care (1977) 0.75
Perceived control: bogus pulse rate feedback and reported symptom reduction for individuals with accumulated stressful life events. Biofeedback Self Regul (1980) 0.75
Mathematical model for chemically induced lipid peroxidation in precision-cut liver slices: computer simulation and experimental calibration. Comput Methods Programs Biomed (1996) 0.75
Essential trace metal excretion from rats with lead exposure and during chelation therapy. J Lab Clin Med (1986) 0.75
Sustained sulfamethazine therapy in cattle. Vet Med Small Anim Clin (1972) 0.75
Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoceptor stimulation in conscious spontaneously hypertensive rats. Cardiovasc Drugs Ther (1987) 0.75
The semantic differential as a tool for measuring progress in therapy. Psychol Rep (1969) 0.75
Reproductive toxicity screen of ammonium dinitramide administered in the drinking water of Sprague-Dawley rats. Toxicol Ind Health (1996) 0.75